Abbott Shares Jump as Q2 Results Top Estimates and High-Growth Units Show Improvement
Abbott Laboratories stock rose sharply in pre-market trading after the company released second-quarter 2026 results that exceeded Wall Street expectations. Management flagged returning double-digit growth for its FreeStyle Libre continuous glucose monitoring business and the first full quarter contribution from the Exact Sciences acquisition booste…